企業プロフィール
Selecta 株価・ニュース・カタリスト
- ティッカー:
- SELB
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for SELB.
企業概要
事業概要
Selecta Biosciences was a biotechnology company focused on immune tolerance and engineered nanoparticles before becoming a historical ticker. Its story centered on using immunology science to create more precise biologic therapies.
所在地とセクター分類
Selecta was headquartered in the United States and listed on NASDAQ. It sat in platform biotechnology and immunology.
ビジネスモデルの特徴
The company depended on clinical data, translational validation, and capital support. Investors historically watched proof-of-concept and strategic development.
バイオ業界での位置付け
Selecta belongs to the historical immunology-platform bucket. It was a science-heavy small-cap name where valuation depended on whether the platform could truly differentiate.
今後のカタリスト
- Selecta’s catalysts are SEL-212 and the gout / immunology program, plus any strategic update that clarifies the company’s future. The company still needs a cleaner clinical or corporate path.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。